506O Evaluation of risk of disease progression in first-line therapy of unresected metastatic colorectal cancer to guide intervals of radiological assessment: An analysis of eleven randomized trials by AIO and GONO. - Germani, M.M.; Heinemann, V.; Rossini, D.; Fischer von Weikersthal, L.; Morano, F.; Heinrich, K.; Stahler, A.; Bergamo, F.; Kaiser, F.; Decker, T.; Salvatore, L.; Weiss, L.; et al. (Annals of Oncology, 2024)